BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 26238235)

  • 1. Genetic variants in the TEP1 gene are associated with prostate cancer risk and recurrence.
    Gu C; Li Q; Zhu Y; Qu Y; Zhang G; Wang M; Yang Y; Wang J; Jin L; Wei Q; Ye D
    Prostate Cancer Prostatic Dis; 2015 Dec; 18(4):310-6. PubMed ID: 26238235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukocyte telomere length is associated with aggressive prostate cancer in localized prostate cancer patients.
    Xu J; Chang WS; Tsai CW; Bau DT; Xu Y; Davis JW; Thompson TC; Logothetis CJ; Gu J
    EBioMedicine; 2020 Feb; 52():102616. PubMed ID: 31981976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic predisposition to early recurrence in clinically localized prostate cancer.
    Borque Á; del Amo J; Esteban LM; Ars E; Hernández C; Planas J; Arruza A; Llarena R; Palou J; Herranz F; Raventós CX; Tejedor D; Artieda M; Simon L; Martínez A; Carceller E; Suárez M; Allué M; Sanz G; Morote J
    BJU Int; 2013 Apr; 111(4):549-58. PubMed ID: 22759231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association analysis of Wnt pathway genes on prostate-specific antigen recurrence after radical prostatectomy.
    Huang SP; Ting WC; Chen LM; Huang LC; Liu CC; Chen CW; Hsieh CJ; Yang WH; Chang TY; Lee HZ; Bao BY
    Ann Surg Oncol; 2010 Jan; 17(1):312-22. PubMed ID: 19777185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms in telomere-associated genes, breast cancer susceptibility and prognosis.
    Varadi V; Brendle A; Brandt A; Johansson R; Enquist K; Henriksson R; Svenson U; Tavelin B; Roos G; Hemminki K; Lenner P; Försti A
    Eur J Cancer; 2009 Nov; 45(17):3008-16. PubMed ID: 19766477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The UGT1 locus is a determinant of prostate cancer recurrence after prostatectomy.
    Laverdière I; Flageole C; Audet-Walsh É; Caron P; Fradet Y; Lacombe L; Lévesque É; Guillemette C
    Endocr Relat Cancer; 2015 Feb; 22(1):77-85. PubMed ID: 25452636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic variants in the Hippo pathway predict biochemical recurrence after radical prostatectomy for localized prostate cancer.
    Huang CY; Huang SP; Lin VC; Yu CC; Chang TY; Juang SH; Bao BY
    Sci Rep; 2015 Feb; 5():8556. PubMed ID: 25707771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A clinicogenetic model to predict lymph node invasion by use of genome-based biomarkers from exome arrays in prostate cancer patients.
    Oh JJ; Park S; Lee SE; Hong SK; Lee S; Lee HM; Lee JK; Ho JN; Yoon S; Byun SS
    Korean J Urol; 2015 Feb; 56(2):109-16. PubMed ID: 25685297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutathione-S-transferase (GST) polymorphisms are associated with relapse after radical prostatectomy.
    Cotignola J; Leonardi DB; Shahabi A; Acuña AD; Stern MC; Navone N; Scorticati C; De Siervi A; Mazza O; Vazquez E
    Prostate Cancer Prostatic Dis; 2013 Mar; 16(1):28-34. PubMed ID: 23146971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative telomere length and prostate cancer mortality.
    Renner W; Krenn-Pilko S; Gruber HJ; Herrmann M; Langsenlehner T
    Prostate Cancer Prostatic Dis; 2018 Nov; 21(4):579-583. PubMed ID: 30082901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single nucleotide polymorphism in ADIPOQ predicts biochemical recurrence after radical prostatectomy in localized prostate cancer.
    Gu C; Qu Y; Zhang G; Sun L; Zhu Y; Ye D
    Oncotarget; 2015 Oct; 6(31):32205-11. PubMed ID: 26320190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variants in telomerase reverse transcriptase (TERT) and telomerase-associated protein 1 (TEP1) and the risk of male infertility.
    Yan L; Wu S; Zhang S; Ji G; Gu A
    Gene; 2014 Jan; 534(2):139-43. PubMed ID: 24269974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of caspases with an increased prostate cancer risk in north Indian population.
    Mittal RD; Mittal T; Singh AK; Mandal RK
    DNA Cell Biol; 2012 Jan; 31(1):67-73. PubMed ID: 21668377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Five-year biochemical recurrence-free and overall survival following high-dose-rate brachytherapy with additional external beam or radical prostatectomy in patients with clinically localized prostate cancer.
    Boehm K; Schiffmann J; Tian Z; Lesmana H; Larcher A; Mandel P; Karakiewicz PI; Graefen M; Schwarz R; Krüll A; Tilki D
    Urol Oncol; 2016 Mar; 34(3):119.e11-8. PubMed ID: 26602027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of prostate cancer susceptibility variants on prostate-specific antigen recurrence after radical prostatectomy.
    Huang SP; Huang LC; Ting WC; Chen LM; Chang TY; Lu TL; Lan YH; Liu CC; Yang WH; Lee HZ; Hsieh CJ; Bao BY
    Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):3068-74. PubMed ID: 19900942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variation of genes involved in dihydrotestosterone metabolism and the risk of prostate cancer.
    Setlur SR; Chen CX; Hossain RR; Ha JS; Van Doren VE; Stenzel B; Steiner E; Oldridge D; Kitabayashi N; Banerjee S; Chen JY; Schäfer G; Horninger W; Lee C; Rubin MA; Klocker H; Demichelis F
    Cancer Epidemiol Biomarkers Prev; 2010 Jan; 19(1):229-39. PubMed ID: 20056642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of genetic variants in cell adhesion pathways on the biochemical recurrence in prostate cancer patients with radical prostatectomy.
    Yu CC; Chen LC; Lin VC; Huang CY; Cheng WC; Hsieh AR; Chang TY; Lu TL; Lee CH; Huang SP; Bao BY
    Cancer Med; 2019 Jun; 8(6):2777-2783. PubMed ID: 30993852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of fibroblast growth factor receptor 4 polymorphisms on biochemical recurrence after radical prostatectomy in a Chinese population.
    Chen L; Lei Z; Ma X; Huang Q; Zhang X; Zhang Y; Hao P; Yang M; Zhao X; Chen J; Liu G; Zheng T
    Sci Rep; 2016 Sep; 6():33604. PubMed ID: 27640814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of solitary and multiple positive surgical margins on hard clinical end points in 1712 adjuvant treatment-naive pT2-4 N0 radical prostatectomy patients.
    Mauermann J; Fradet V; Lacombe L; Dujardin T; Tiguert R; Tetu B; Fradet Y
    Eur Urol; 2013 Jul; 64(1):19-25. PubMed ID: 22901983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Cigarette Smoking and Smoking Cessation with Biochemical Recurrence of Prostate Cancer in Patients Treated with Radical Prostatectomy.
    Rieken M; Shariat SF; Kluth LA; Fajkovic H; Rink M; Karakiewicz PI; Seitz C; Briganti A; Rouprêt M; Loidl W; Trinh QD; Bachmann A; Pourmand G
    Eur Urol; 2015 Dec; 68(6):949-56. PubMed ID: 26050111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.